Validity of Urine Specific Gravity When Compared With Plasma Osmolality as a Measure of Hydration Status in Male and Female NCAA Collegiate Athletes.

Sommerfield, LM, McAnulty, SR, McBride, JM, Zwetsloot, JJ, Austin, MD, Mehlhorn, JD, Calhoun, MC, Young, JO, Haines, TL, and Utter, AC. Validity of urine specific gravity when compared with plasma osmolality as a measure of hydration status in male and female NCAA collegiate athletes. J Strength Cond Res 30(8): 2219-2225, 2016-The purpose of this study was to evaluate the response of urine specific gravity (Usg) and urine osmolality (Uosm) when compared with plasma osmolality (Posm) from euhydration to 3% dehydration and then a 2-hour rehydration period in male and female collegiate athletes. Fifty-six National Collegiate Athletic Association (NCAA) wrestlers (mean ± SEM); height 1.75 ± 0.01 m, age 19.3 ± 0.2 years, and body mass (BM) 78.1 ± 1.8 kg and 26 NCAA women's soccer athletes; height 1.64 ± 0.01 m, age 19.8 ± 0.3 years, and BM 62.2 ± 1.2 kg were evaluated. Hydration status was obtained by measuring changes in Posm, Uosm, Usg, and BM. Male and female subjects dehydrated to achieve an average BM loss of 2.9 ± 0.09% and 1.9 ± 0.03%, respectively. Using the medical diagnostic decision model, the sensitivity of Usg was high in both the hydrated and dehydrated state for males (92%) and females (80%). However, the specificity of Usg was low in both the hydrated and dehydrated states for males (10 and 6%, respectively) and females (29 and 40%, respectively). No significant correlations were found between Usg and Posm during either the hydrated or dehydrated state for males or females. Based on these results, the use of Usg as a field measure of hydration status in male and female collegiate athletes should be used with caution. Considering that athletes deal with hydration status on a regular basis, the reported low specificity of Usg suggests that athletes could be incorrectly classified leading to the unnecessary loss of competition.

Validity of COSMED's quark CPET mixing chamber system in evaluating energy metabolism during aerobic exercise in healthy male adults.

This study validated the accuracy of COSMED's Quark cardiopulmonary exercise testing (CPET) metabolic mixing chamber system in measuring metabolic factors during maximal, graded exercise testing. Subjects included 32 physically active men between the ages of 18 and 34 years. During the first test session, subjects were measured for maximal oxygen consumption twice (15 min separation) with the CPET and Douglas bag systems (random order). During the second test session, subjects exercised through four stages of the Bruce treadmill protocol with measurement by the CPET and Douglas bag systems (random order) during steady state at the end of each 3-minute stage. Statistical analysis using a 2 (systems) x 5 (time) repeated measures ANOVA showed that the pattern of change in VO2, VCO2, VE, FeO2, FeCO2, and RER did not differ significantly between CPET and Douglas bag systems. This validation study indicates that the CPET mixing chamber system provides valid metabolic measurements that compare closely with the Douglas bag system during aerobic exercise.

Quercetin with vitamin C and niacin does not affect body mass or composition.

In vitro and animal data suggest that quercetin affects adipogenesis and basal metabolism; however, whether this metabolic effect translates to reductions in body mass or improvement in body composition in humans is unknown. This study investigated 12-week supplementation of 2 different doses of quercetin, combined with vitamin C and niacin, on body mass and composition in a large, heterogeneous group of adults (n = 941; 60% female, 40% male; 18-85 years of age; 45% normal body mass index, 30% overweight, 25% obese). Subjects were randomized into 3 groups, with supplements administered in double-blind fashion: Q500 = 500 mg quercetin·day(-1), Q1000 = 1000 mg quercetin·day(-1), and placebo. Quercetin supplements were consumed twice daily over a 12-week period, and pre- and poststudy body mass and composition measurements were taken in an overnight fasted state. A general linear model was used to predict change in body mass and composition across groups with adjustment for demographic and lifestyle factors. Plasma quercetin increased in a dose-responsive manner in both Q500 and Q1000 groups relative to placebo. After adjustment for confounders, no significant differences in body mass (males interaction p value = 0.721, females p = 0.366) or body composition (males p = 0.650, females p = 0.639) were found between Q500 or Q1000 groups compared with placebo. No group differences in body mass or body composition were found in a subgroup of overweight and obese subjects. High-dose quercetin supplementation (500 and 1000 mg·day(-1)) for 12 weeks in a large, heterogeneous group of adults did not affect body mass or composition.

Influence of quercetin supplementation on disease risk factors in community-dwelling adults.

BACKGROUND: In vitro data indicate quercetin has antioxidative and anti-inflammatory functions with the potential to lower disease risk factors, but data in human beings are limited. OBJECTIVE: The objective of this study was to investigate the effect of quercetin, vitamin C, and niacin supplements (500 mg quercetin, 125 mg vitamin C, and 5 mg niacin [Q-500]; 1,000 mg quercetin, 250 mg vitamin C, and 10 mg niacin [Q-1,000]), on disease risk factors in a large group of community adults (n=1,002, 60% women) varying widely in age and body mass index. DESIGN: Subjects were randomized into one of three groups (placebo, Q-500, or Q-1,000) and ingested supplements for 12 weeks. Blood samples were taken pre- and postsupplementation, and plasma quercetin, inflammatory markers (ie, C-reactive protein and five cytokines), diagnostic blood chemistries, blood pressure, and blood lipid profiles were measured. RESULTS: Plasma quercetin increased in the Q-500 and Q-1,000 groups. No differences in blood chemistries were found except for a small decrease in serum creatinine and increase in glomerular filtration rate in Q-500 and Q-1,000 groups. A small decrease in mean arterial blood pressure was measured for Q-500 and Q-1,000 groups compared to placebo. A difference in serum total cholesterol was measured between Q-500 and placebo groups, and there was small decrease in high-density lipoprotein cholesterol levels in the Q-1,000 group. Change in inflammatory measures did not differ between groups except for a slight decrease in interleukin-6 for the Q-1,000 group. CONCLUSIONS: Q-500 or Q-1,000 supplementation for 12 weeks had a negligible influence on disease risk factors.

Upper respiratory tract infection is reduced in physically fit and active adults.

OBJECTIVE: Limited data imply an inverse relationship between physical activity or fitness level and the rates of upper respiratory tract infection (URTI). The purpose of this study was to monitor URTI symptoms and severity in a heterogeneous group of community adults and contrast across tertiles of physical activity and fitness levels while adjusting for potential confounders. DESIGN: A group of 1002 adults (ages 18-85 years, 60% female, 40% male) were followed for 12 weeks during the winter and fall seasons while monitoring URTI symptoms and severity using the Wisconsin Upper Respiratory Symptom Survey. Subjects reported frequency of aerobic activity, and rated their physical fitness level using a 10-point Likert scale. A general linear model, with adjustment for seven confounders, was used to examine the effect of exercise frequency and fitness level on the number of days with URTI and severity of symptoms. RESULTS: The number of days with URTI during the 12-week period was significantly reduced, 43% in subjects reporting ≥ 5 days/week aerobic exercise compared to those who were largely sedentary (≤ 1 day/week) and 46% when comparing subjects in the high versus low fitness tertile. URTI severity and symptomatology were also reduced 32% to 41% between high and low aerobic activity and physical fitness tertiles. CONCLUSIONS: Perceived physical fitness and frequency of aerobic exercise are important correlates of reduced days with URTI and severity of symptoms during the winter and fall common cold seasons.

Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial.

Quercetin in culture with target cells and pathogens exerts anti-pathogenic activities against a wide variety of viruses and bacteria. A few small-scale human quercetin supplementation studies have produced conflicting results regarding quercetin's effects on upper respiratory tract infection rates, and little is known regarding the appropriate human dose. The purpose of this randomized, double-blinded, placebo-controlled trial was to measure the influence of two quercetin doses (500 and 1000 mg/day) compared to placebo on upper respiratory tract infection (URTI) rates in a large community group (N=1002) of subjects varying widely in age (18-85 years). Subjects ingested supplements for 12 weeks and logged URTI symptoms on a daily basis using the Wisconsin Upper Respiratory Symptom Survey (WURSS). No significant group differences were measured for URTI outcomes for all subjects combined, or when analyzing separately by gender, body mass index, and age categories. Regression analysis revealed that the strongest interaction effect with group status was self-reported fitness level. A separate analysis of subjects 40 years of age and older rating themselves in the top half of the entire group for fitness level (N=325) showed lower URTI severity (36% reduction, P=0.020) and URTI total sick days (31% reduction, P=0.048) for the Q-1000 group compared to placebo. In summary, for all subjects combined, quercetin supplementation over 12 weeks had no significant influence on URTI rates or symptomatology compared to placebo. A reduction in URTI total sick days and severity was noted in middle aged and older subjects ingesting 1000 mg quercetin/day for 12 weeks who rated themselves as physically fit.

A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects.

Quercetin, a flavonoid found in fruits and vegetables, is a strong antioxidant with anti-inflammatory, antimicrobial and immune-modulating properties. The purpose of the present study was to investigate the effects of long-term quercetin supplementation on innate immune function and inflammation in human subjects. Female subjects (n 120; aged 30-79 years) were recruited from the community and randomised to one of three groups, with supplements administered using double-blinded procedures: 500 mg quercetin/d (n 38), 1000 mg quercetin/d (n 40) or placebo (n 42). Subjects ingested two soft chew supplements twice daily during the 12-week study period. Fasting blood samples were obtained pre- and post-study and were analysed for plasma quercetin, IL-6, TNF-alpha and leucocyte subset cell counts. Natural killer cell activity (NKCA) and lymphocyte subsets were assessed in a subset of seventy-four subjects. Granulocyte oxidative burst activity (GOBA) and phagocytosis were assessed in sixty-four subjects. Eighteen subjects had overlapping data. Quercetin supplementation at two doses compared with placebo increased plasma quercetin (interaction effect; P < 0.001) but had no significant influence on blood leucocyte subsets, plasma IL-6 or TNF-alpha concentration, NKCA, GOBA or phagocytosis. NKCA was inversely correlated with BMI (r - 0.25; P = 0.035) and body fat percentage (r - 0.38; P = 0.001), and positively correlated with self-reported physical fitness level (r 0.24; P = 0.032). In summary, results from the present double-blinded, placebo-controlled, randomised trial indicated that quercetin supplementation at 500 and 1000 mg/d for 12 weeks significantly increased plasma quercetin levels but had no influence on measures of innate immune function or inflammation in community-dwelling adult females.

Quercetin's influence on exercise performance and muscle mitochondrial biogenesis.

PURPOSE: To determine the influence of 2 wk of quercetin (Q; 1000 mg x d(-1)) compared with placebo (P) supplementation on exercise performance and skeletal muscle mitochondrial biogenesis in untrained, young adult males (N = 26, age = 20.2 +/- 0.4 yr, VO2max = 46.3 +/- 1.2 mL x kg(-1) x min(-1)). METHODS: Using a randomized, crossover design with a 2-wk washout period, subjects provided blood and muscle biopsy samples presupplementation and postsupplementation periods and were given 12-min time trials on 15% graded treadmills after 60 min of moderate exercise preloads at 60% VO2max. RESULTS: Plasma Q levels rose significantly in Q versus P during the 2-wk supplementation period (interaction P value <0.001). During the 12-min trial, the net change in distance achieved was significantly greater during Q (2.9%) compared with P (-1.2%; 29.5 +/- 11.5 vs -11.9 +/- 16.0 m, respectively, P = 0.038). Skeletal muscle messenger RNA expression tended to increase (range = 16-25%) during Q versus P for sirtuin 1 (interaction effect, P = 0.152), peroxisome proliferator-activated receptor gamma coactivator-1alpha (P = 0.192), cytochrome c oxidase (P = 0.081), and citrate synthase (P = 0.166). Muscle mitochondrial DNA (relative copy number per diploid nuclear genome) increased 140 +/- 154 (4.1%) with Q compared with -225 +/- 157 (6.0% decrease) with P (P = 0.098). CONCLUSIONS: In summary, 1000 mg x d(-1) Q versus P for 2 wk by untrained males was associated with a small but significant improvement in 12-min treadmill time trial performance and modest but insignificant increases in the relative copy number of mitochondrial DNA and messenger RNA levels of four genes related to mitochondrial biogenesis.

Chia seed does not promote weight loss or alter disease risk factors in overweight adults.

The objective of this study was to assess the effectiveness of chia seed (Salvia hispanica L) in promoting weight loss and altering disease risk factors in overweight adults. The hypothesis was that the high dietary fiber and alpha-linolenic (ALA) contents of chia seed would induce a small but significant decrease in body weight and fat and improve disease risk factors. Subjects were randomized to chia seed (CS) and placebo (P) groups, and under single-blinded procedures, ingested 25 g CS or P supplements mixed in 0.25 L water twice daily before the first and last meal for 12 weeks. Ninety nondiseased, overweight/obese men and women between the ages of 20 and 70 years were recruited into the study, with 76 subjects (n = 39 CS, n = 37 P) completing all phases of the study. Pre- and poststudy measures included body mass and composition (dual energy x-ray absorptiometry), inflammation markers from fasting blood samples (C-reactive protein, interleukin 6, monocyte chemoattractant protein 1, and tumor necrosis factor alpha), oxidative stress markers (trolox equivalent antioxidant capacity and plasma nitrite), blood pressure, and a serum lipid profile. Plasma ALA increased 24.4% compared to a 2.8% decrease in CS and P, respectively (interaction effect, P = .012). No group differences were measured for changes in plasma eicosapentaenoic acid and docosahexaenoic acid (interaction effects, P = .420 and .980, respectively). Pre-to-post measures of body composition, inflammation, oxidative stress, blood pressure, and lipoproteins did not differ between CS and P for both sexes. In conclusion, ingestion of 50 g/d CS vs P for 12 weeks by overweight/obese men and women had no influence on body mass or composition, or various disease risk factor measures.

Validation of Cosmed's FitMate in measuring exercise metabolism.

The purpose of this study was to assess the validity of the FitMate metabolic system (Cosmed, Rome, Italy) in measuring oxygen consumption during graded exercise. The FitMate is a new, small (20 x 24 cm) metabolic analyzer designed for measurement of oxygen consumption during rest and exercise. Subjects included 40 healthy adults (N = 20 males, N = 20 females) ranging in age from 18 to 37 kg/m2 (mean +/- SD age, 22.5 +/- 3.6 years) and body mass index (BMI) from 18.3 to 32.5 kg/m2 (23.2 +/- 3.3 years). One-minute FitMate and Douglas bag measurements were made during steady state conditions at the end of each 3-minute stage of the Bruce treadmill graded exercise test, and subjects continued until they could not attain steady state exercise during a stage. Oxygen consumption difference scores (Douglas bag minus FitMate measurements) did not differ between males and females, so data were combined and analyzed for the entire group. During the first three stages, mean oxygen consumption did not differ significantly between the Douglas bag and FitMate systems (26.5 +/- 1.1 and 26.7 +/- 1.3 ml.kg-1.min-1, respectively, P = 0.140) with a mean absolute difference of 0.23 +/- 0.91 ml.kg-1.min-1 or 14.2 +/- 67.5 ml.min-1. In conclusion, the FitMate metabolic system accurately measures oxygen consumption during graded treadmill exercise when compared with the Douglas bag system in male and female adults.

Validation of Cosmed's FitMate in measuring oxygen consumption and estimating resting metabolic rate.

The purpose of this study was to assess the validity and reliability of the FitMate metabolic system (Cosmed, Rome, Italy) in measuring oxygen consumption and estimating resting metabolic rate (RMR). The FitMate is a new, small (20 x 24 cm) metabolic analyzer designed for measurement of oxygen consumption and energy expenditure during rest and exercise. Subjects included 60 healthy adults (N = 30 males, N = 30 females) ranging in age from 19 to 65 years (mean +/- SD age, 36.9 +/- 13.4 years) and body mass index (BMI) from 19.2 to 44.8 kg/m2 (27.7 +/- 6.2 kg/m2). Subjects were given two 10 min RMR tests in one test session during which RMR was measured simultaneously with the Douglas bag and FitMate systems. No significant differences were found between Douglas bag and FitMate systems for oxygen consumption (242 +/- 49 and 240 +/- 49 ml/min, respectively, P = 0.066, r = 0.97, mean +/- SD absolute difference 2.83 +/- 11.68 ml/min) or RMR (1,662 +/- 340 and 1,668 +/- 344 kcal/day, P = 0.579, r = 0.97, mean +/- SD absolute difference 5.81 +/- 80.70 kcal/day). These data indicate that the FitMate is a reliable and valid system for measuring oxygen consumption and RMR in adults.

Validation of a new handheld device for measuring resting metabolic rate and oxygen consumption in children.

The purpose of this study was to assess the validity and reliability of the MedGem device to measure resting metabolic rate (RMR) in children. Subjects included 59 children (29 boys, 30 girls; mean age, 11.0 +/- 0.2 y). Subjects were given 4 RMR tests during 1 test session, cconsisting of 2 Douglas bag and 2 MedGem tests, in random counterbalanced order. No significant differences were found between Douglas bag and MedGem systems for oxygen consumption (209 +/- 5 and 213 +/- 5 mL/min, respectively, P = 0.106, r = 0.911, mean +/- standard deviation absolute difference 3.72 +/- 17.40 mL/min) or RMR (1460 +/- 39 and 1477 +/- 35 kcal/d, P = 0.286, r = 0.909, mean +/- standard deviation absolute difference 17.4 +/- 124 kcal/d). Standard error of estimates for oxygen consumption and RMR were 17.4 mL/min and 124 kcal/d, respectively. In conclusion, these data indicate that the MedGem is a reliable and valid system for measuring oxygen consumption and RMR in children.

Immune response to a 30-minute walk.

PURPOSE: To measure several components of immune changes related to walking 30 min with or without an exercise assist device compared with sitting. METHODS: Fifteen healthy and nonobese female subjects (37.5 +/- 3.1 yr of age) accustomed to regular walking were recruited and tested for aerobic power (VO(2max) 34.4 +/- 1.4 mL.kg(-1).min(-1)). During three randomly assigned 30-min test sessions, subjects functioned as their own controls and either sat in the laboratory, walked at approximately 60% VO(2max), or walked at the same treadmill speed using the BODY BAT Aerobic Exerciser. This exercise assist device resembles a pair of baseball bats seamlessly joined together and is held with both hands and swung to shoulder height across the body in a natural side to side pendulum motion. Saliva and blood samples were collected pre- and postexercise, and 1 h postexercise, with the data statistically analyzed using a 3 x 3 repeated measures ANOVA. RESULTS: Walking with the exercise assist device increased oxygen consumption 11 +/- 2% and heart rate 8 +/- 2 beats.min(-1). The pattern of increase in blood counts for neutrophils, lymphocytes, monocytes, and natural killer cells, plasma interleukin-6 concentration, and PHA-induced lymphocyte proliferation differed significantly when comparing walking with sitting, but no differences were found between walking with or without the exercise assist device. No significant increases over time or interaction effects were measured for plasma cortisol concentration, salivary IgA output, or plasma interleukin-1 receptor antagonist concentration. CONCLUSIONS: The use of an exercise assist device increased oxygen consumption 11% during walking, but did not alter the pattern of change in several components of immunity measured during walking alone in comparison to sitting. Walking caused modest and short-lived changes in immune parameters, most notably for neutrophil and natural killer blood cell counts.

A new handheld device for measuring resting metabolic rate and oxygen consumption.

OBJECTIVE: The purpose of this study was to test a new handheld device, the BodyGem (HealtheTech Inc., Golden, CO), that measures resting metabolic rate (RMR). SUBJECTS/DESIGN: Sixty-three adults (43 women, 20 men) (mean+/-SD, age 41.3+/-11.2 years and body mass index, 26.5+/-6.6 kg/m(2)) were tested during two separate sessions within a 2-week period, and, in each session, two BodyGem and two Douglas bag RMR measurements were made in a random and counterbalanced order. MAIN OUTCOME MEASURES: Resting oxygen consumption and energy expenditure. STATISTICAL ANALYSES PERFORMED: A 2 (methods) x 4 (time points) repeated measures ANOVA, Pearson product-moment coefficients, Bland-Altman plots. RESULTS: Within session reliability for measurement of O(2), consumption was high on both days for the BodyGem (r=0.97). During the 4 single tests, BodyGem and Douglas bag O(2) consumption values were significantly correlated (r=0.81-0.87), with SEEs ranging from 22 to 28 mL. min(-1). Mean O(2) consumption and RMR values for all 4 tests were 241+/-46 and 240+/-45 mL x min(-1) (r=0.91, SEE 18.7 mL x min(-1)) and 1,657+/-324 and 1,650+/-307 kcals x day(-1) (r=0.91, SEE 134 kcals x day(-1)) for the BodyGem and Douglas bag methods, respectively. APPLICATIONS/CONCLUSIONS: These data indicate that the BodyGem is an accurate and reliable device for measuring oxygen consumption and calculating RMR during repeated tests within a day, single tests on separate days, or when measurements are averaged.